Article info
Commentary
The IL-33/ST2 axis: yet another therapeutic target in inflammatory bowel disease?
- Correspondence to Dr Azucena Salas, Center Esther Koplowitz-IDIBAPS-CIBERehd, Rosselló 149-153, Barcelona 08036, Spain; asalas1{at}clinic.ub.es
Citation
The IL-33/ST2 axis: yet another therapeutic target in inflammatory bowel disease?
Publication history
- First published January 11, 2013.
Online issue publication
April 18, 2016
Article Versions
- Previous version (18 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions